BSE filing, NSE: APLLTD. Summary written from the filing by ALFA Finder's alert engine.
Alembic Pharmaceuticals Ltd: key numbers
- Share price
- ₹797.85
- Market cap
- ₹15,683 Cr
- Revenue (annual)
- ₹7,345 Cr
- Net profit (annual)
- ₹674.8 Cr
- P/E (TTM)
- 22.6×Sector 45.9×
- Promoter holding
- 69.87%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alembic Pharmaceuticals Ltd
All →Alembic Pharmaceuticals Board Meeting Date
Alembic Pharmaceuticals scheduled its board meeting for November 4, 2026, to consider unaudited Q1/H1 FY27 results. Trading window re-opens 48 hours post-declaration.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.
Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.26 Cr
Alembic Pharmaceuticals' subsidiary, Alembic Global Holding SA, incorporated a new wholly-owned subsidiary, Alvesta Pharmaceuticals FZCO, in the UAE for Rs. 0.26 Crore.
- Value
- ₹0.26 Cr
Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.23 Cr
Alembic Pharmaceuticals' wholly-owned subsidiary, Alembic Global Holding SA, incorporated a new step-down subsidiary, Alvesta Pharmaceuticals FZCO, in Dubai for AED 1 Lakh (approx. ₹0.23 Crore).
- Value
- ₹0.23 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP. This drug is therapeutically equivalent to the reference product Ciprodex Otic Suspension.
Alembic Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Other business update announcements
All →MOIL Business Update
MOIL Limited kept Manganese Ore prices unchanged for November 2026, carrying forward October rates. The filing reports a routine price confirmation with no new revenue impact disclosed.
Aavas Financiers Business Update
AAVAS Financiers crossed Rs. 25,000 Crore in Assets Under Management, a milestone with 443 branches and over 3.8 lakh families served. The filing is a press release with no new transaction or financial figures.
Seamec Business Update
Seamec's vessel SEAMEC II was onhired from November 1, 2026 for the PRP-8A and DSF 2 project. No contract value or client was disclosed in this filing.
TVS Motor Company Business Update
TVS Motor's October 2026 sales rose 29% to 700,134 units from 543,557 a year earlier. Two-wheeler EV sales grew 120% to 71,382 units.
Lemon Tree Hotels Business Update
Lemon Tree Hotels rebranded three existing hotels in Bengaluru and Hyderabad effective 1 November 2026 following renovation. The changes move two properties to the upscale Lemon Tree Premier brand and one to Lemon Tree Hotel, with no new capacity or monetary amount disclosed.
VST Tillers Tractors Business Update
VST Tillers Tractors reported October 2026 unaudited sales of 3,519 units, down from 4,664 a year earlier. Year-to-date sales were 33,103 units against 32,069 units last year.